In this video, Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, highlights the numerous novel drugs that have been approved for the treatment of multiple myeloma, as well as those to come, including antibodies, inhibitors, immunomodulatory drugs (IMiDs) and more. Preliminary findings and applications of these novel agents will be addressed at the 2022 COMy congress in Paris, France.